glp-1 use Receptor Agonists and Research to Treat Overeating and Substance Disorders GLP-1 agonists approved for clinical

These agents target multiple hormone pathways involved in appetite regulation, insulin secretion, energy expenditure, and hepatic metabolism

(PubMed)

GLP-1s like Ozempic, Wegovy, and Mounjaro have gained a lot of media attention for weight loss, but how do these weight-loss injections work

Glucagon-like peptide-1 (GLP-1) receptor agonists, especially semaglutide, are associated with a reduced risk for worsening of anxiety and depression that co-oc

Method The PubMed (MEDLINE), EMBASE, Cochrane Library, and ClinicalTrials.gov databases were searched from the establishment of the database to December 24, 2022

### Competing Interest Statement TR, IG, TK, YW, DT are employees of Olio Labs Incorporated